Darwin AG is the parent company of the Austrian Novogenia GmbH, which is one of Europe's leading biotechnology companies in the field of human genetics. The company's own laboratory carries out genetic analyses that are used in the diagnosis, treatment and prevention of diseases as well as in the production of individually designed food supplements and cosmetics. Novogenia sees itself as a partner to doctors, therapists, pharmacists, nutritionists and fitness trainers. By analyzing the respective genetic predisposition of the patient or customer, the aim is to ensure the best possible treatment or care for their needs. Darwin is also involved as an investor in the biotechnology and healthcare sector.
| Type | Document | Details | Language | Filing Date | File Number |
|---|
Access comprehensive European stock market filings data through a single, powerful API.
1,5M+
filings covered
18
European countries
30min
max latency
1 API
for all filings
Limited spots available. Join now!
We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.
DE000A3C35W0
391200XJOD6U0EW7OE14
m:access All-Share Index GTR
ABAS
Sector
Country
Sweden
ISIN
SE0018588659
Founded
ABAS Protect develops, manufactures, and sells area protection primarily to industry, and public administrations, but also to private individuals. The …
ABERA
Sector
Country
Sweden
ISIN
SE0015245097
Founded
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed …
ABI
Sector
Country
Sweden
ISIN
SE0006091476
Founded
Igrene is an exploration company with a main focus on gas and oil. The largest part of the business activity …
None
Sector
Country
Russia
ISIN
RU000A0JS5T7
Founded
Abrau-Durso is a prominent Russian producer of sparkling wine , which uses traditional methods to create their products. The company …
